Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity

Author： Neafsey Patricia  

Publisher： Taylor & Francis Ltd

ISSN： 1521-6950

Source： Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol.12, Iss.5-6, 2009-05, pp. : 334-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paroxetine metabolism is affected by cytochrome P450 (CYP) 2D6 polymorphism

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Reduced cytochrome P450 (CYP) 2D6 activity may contribute to an interaction between tramadol and warfarin

By  

Reactions Weekly, Vol. 1, Iss. 1017, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Genetic variations in cytochrome P450 (CYP) 2D6 activity may have important clinical consequences for some drugs

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 5, 2010-05 ,pp. : 21-26

Adis International

Access to resources Recommend Favorite

An Evaluation of Ondansetron Binding Interactions with Human Cytochrome P450 Enzymes CYP3A4 and CYP2D6

By  

Drug Metabolism Letters, Vol. 4, Iss. 1, 2010-01 ,pp. : 25-30

Bentham Science Publishers

Access to resources Recommend Favorite

Bupropion [amfebutamone] sustained-release (SR) is a potent inhibitor of cytochrome P450 (CYP)2D6

By  

Reactions Weekly, Vol. 1, Iss. 1063, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite